Robbins B, Welser HT, Grigoryeva M, Gleave E: Power-use in cooperative competition: A power-dependence model and an empirical test of network structure and geographic mobility. Soc Sci Res. 2014, 45: 131-151.
Article
PubMed
Google Scholar
Keller BJ, Martini S, Sedor JR, Kretzler M: A systems view of genetics in chronic kidney disease. Kidney Int. 2012, 81: 14-21. 10.1038/ki.2011.359.
Article
CAS
PubMed
Google Scholar
D'Agati VD, Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis. N Engl J Med. 2011, 365: 2398-2411. 10.1056/NEJMra1106556.
Article
PubMed
Google Scholar
Raggam RB, Wagner J, Prüller F, Grisold A, Leitner E, Zollner-Schwetz I, Valentin T, Krause R, Hoenigl M: Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in patients with systemic inflammatory response syndrome (SIRS). J Intern Med. 2014, doi: 10.1111/joim.12238. [Epub ahead of print]
Google Scholar
Donadello K, Scolletta S, Taccone FS, Covajes C, Santonocito C, Cortes DO, Grazulyte D, Gottin L, Vincent JL: Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients. J Crit Care. 2014, 29: 144-149. 10.1016/j.jcrc.2013.08.005.
Article
CAS
PubMed
Google Scholar
Wrotek A, Pawlik K, Jackowska T: Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children. Adv Exp Med Biol. 2013, 788: 329-334. 10.1007/978-94-007-6627-3_44.
Article
CAS
PubMed
Google Scholar
Hoenigl M, Raggam RB, Wagner J, Valentin T, Leitner E, Seeber K, Zollner-Schwetz I, Krammer W, Prüller F, Grisold AJ, Krause R: Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem. 2013, 46: 225-229. 10.1016/j.clinbiochem.2012.11.004.
Article
CAS
PubMed
Google Scholar
Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011, 17: 952-960. 10.1038/nm.2411.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wei C, Trachtman H, Li J, Dong C, Friedman AL, Gassman JJ, McMahan JL, Radeva M, Heil KM, Trautmann A, Anarat A, Emre S, Ghiggeri GM, Ozaltin F, Haffner D, Gipson DS, Kaskel F, Fischer DC, Schaefer F, Reiser J: PodoNet and FSGS CT study consortia: circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol. 2012, 23: 2051-2059. 10.1681/ASN.2012030302.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Chen Y, Zhao MH: Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis. Kidney Int. 2013, 84: 366-372. 10.1038/ki.2013.55.
Article
CAS
PubMed
Google Scholar
Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH: CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol. 2013, [Epub ahead of print]
Google Scholar
Bock ME, Price HE, Gallon L, Langman CB: Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol. 2013, 8: 1304-1311. 10.2215/CJN.07680712.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meijers B, Maas RJ, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JK, Dietrich R, Storr M, Wetzels JF, Evenepoel P, Kuypers D: The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int. 2014, 85: 636-640. 10.1038/ki.2013.505.
Article
CAS
PubMed
Google Scholar
Wada T, Nangaku M, Maruyama S, Imai E, Shoji K, Kato S, Endo T, Muso E, Kamata K, Yokoyama H, Fujimoto K, Obata Y, Nishino T, Kato H, Uchida S, Sasatomi Y, Saito T, Matsuo S: A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int. 2014, 85: 641-648. 10.1038/ki.2013.544.
Article
CAS
PubMed
Google Scholar
Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, Dinda AK, Agarwal SK, Sopory S, Pandey RM, Hari P, Bagga A: Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int. 2014, 85: 649-658. 10.1038/ki.2013.546.
Article
CAS
PubMed
Google Scholar
Segarra A, Jatem E, Quiles MT, Arbós MA, Ostos H, Valtierra N, Carnicer C, Agraz I, Salcedo MT: Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome [Article in Spanish]. Nefrologia. 2014, 34: 46-52.
PubMed
Google Scholar
Segarra A, Jatem E, Quiles MT, Arbós MA, Ostos H, Valtierra N, Carnicer C, Salcedo MT: Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis [Article in Spanish]. Nefrologia. 2014, 34: 53-61.
PubMed
Google Scholar
Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Zhao MH: Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis. BMC Med. 2014, 12: 81.
Article
PubMed
PubMed Central
Google Scholar
Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC: Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation. 2013, 96: 394-399. 10.1097/TP.0b013e3182977ab1.
Article
CAS
PubMed
Google Scholar
Reiser J: Circulating permeability factor suPAR: from concept to discovery to clinic. Trans Am Clin Climatol Assoc. 2013, 124: 133-138.
PubMed
PubMed Central
Google Scholar
Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW, Mundel P: Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2013, 369: 2416-2423. 10.1056/NEJMoa1304572.
Article
CAS
PubMed
PubMed Central
Google Scholar
Benigni A, Gagliardini E, Remuzzi G: Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2014, 370: 1261-1263.
Article
CAS
PubMed
Google Scholar
Alachkar N, Carter-Monroe N, Reiser J: Abatacept in B7–1-positive proteinuric kidney disease. N Engl J Med. 2014, 370: 1263-1264.
PubMed
Google Scholar
Schlöndorff D: Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?. Kidney Int. 2014, 85: 499-501. 10.1038/ki.2013.549.
Article
PubMed
Google Scholar
Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, et al: Design of the nephrotic syndrome study network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int. 2013, 83: 749-756. 10.1038/ki.2012.428.
Article
PubMed
PubMed Central
Google Scholar